26 | CrizotinibIBA
01/2020
-
05/2007 |
23 | Phosphotransferases (Kinase)IBA
01/2015
-
09/2003 |
12 | Tyrosine Kinase InhibitorsIBA
01/2019
-
10/2004 |
12 | Sunitinib (Sutent)FDA Link
06/2013
-
01/2003 |
11 | Proteins (Proteins, Gene)FDA Link
10/2022
-
07/2005 |
11 | Anaplastic Lymphoma KinaseIBA
01/2015
-
12/2007 |
11 | Proto-Oncogene Proteins c-metIBA
07/2012
-
09/2003 |
10 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2013
-
11/2003 |
9 | Pharmaceutical PreparationsIBA
10/2022
-
02/2006 |
9 | ErbB Receptors (EGF Receptor)IBA
10/2012
-
06/2005 |
9 | 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
02/2011
-
11/2003 |
8 | adagrasibIBA
10/2022
-
01/2020 |
7 | Biomarkers (Surrogate Marker)IBA
12/2013
-
06/2005 |
6 | LigandsIBA
01/2022
-
11/2003 |
6 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2014
-
07/2005 |
6 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2011
-
09/2003 |
4 | 2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
11/2014
-
11/2011 |
4 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2013
-
11/2008 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013
-
06/2005 |
4 | 2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
06/2013
-
01/2012 |
3 | Tyrosine (L-Tyrosine)FDA Link
01/2018
-
06/2005 |
3 | dacomitinibIBA
11/2014
-
02/2012 |
3 | Docetaxel (Taxotere)FDA Link
03/2013
-
07/2009 |
3 | Lapatinib (GW572016)FDA Link
09/2012
-
02/2012 |
3 | Trastuzumab (Herceptin)FDA Link
09/2012
-
07/2005 |
3 | Angiogenesis InhibitorsIBA
07/2012
-
10/2007 |
3 | tyrosine receptor (receptor, tyrosine)IBA
04/2012
-
05/2006 |
3 | Gefitinib (Iressa)FDA Link
02/2012
-
07/2005 |
3 | Biological ProductsIBA
11/2010
-
10/2004 |
3 | ((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
04/2009
-
09/2003 |
2 | PlatinumIBA
01/2022
-
12/2013 |
2 | Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021
-
06/2013 |
2 | Codon (Codons)IBA
01/2021
-
06/2013 |
2 | Histone Deacetylases (Histone Deacetylase)IBA
01/2019
-
01/2018 |
2 | mocetinostatIBA
01/2019
-
01/2018 |
2 | Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2016
-
11/2011 |
2 | Sirolimus (Rapamycin)FDA Link
11/2014
-
03/2005 |
2 | palbociclibIBA
07/2014
-
08/2013 |
2 | figitumumabIBA
12/2013
-
07/2011 |
2 | Insulin-Like PeptidesIBA
12/2013
-
03/2012 |
2 | mirdametinibIBA
12/2013
-
08/2012 |
2 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2013
-
02/2012 |
2 | nirogacestatIBA
03/2013
-
09/2012 |
2 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2013
-
09/2012 |
2 | AfatinibIBA
10/2012
-
02/2012 |
2 | Messenger RNA (mRNA)IBA
09/2012
-
06/2005 |
2 | Small Interfering RNA (siRNA)IBA
04/2012
-
02/2005 |
2 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2012
-
04/2012 |
2 | N- (2- (6- (4- cyclobutylamino- 5- trifluoromethylpyrimidine- 2- ylamino)- 1,2,3,4- tetrahydro- 1,4- epiazano- naphthalen- 9- yl)- 2- oxo- ethyl)acetamideIBA
03/2012
-
04/2010 |
2 | Canertinib (CI 1033)IBA
02/2012
-
06/2005 |
2 | Phosphatidylinositols (Phosphatidylinositol)IBA
11/2011
-
11/2008 |
2 | Adenosine Triphosphate (ATP)IBA
08/2011
-
11/2003 |
2 | Semaphorins (Semaphorin)IBA
04/2009
-
02/2005 |
2 | Growth Factor ReceptorsIBA
11/2008
-
02/2006 |
2 | Imatinib Mesylate (Gleevec)FDA Link
05/2006
-
07/2005 |
2 | Mesylates (Mesylate)IBA
05/2006
-
06/2005 |
1 | symmetric dimethylarginineIBA
10/2022 |
1 | KRASG12D inhibitor MRTX1133IBA
01/2022 |
1 | B7-H1 AntigenIBA
01/2022 |
1 | Cysteine (L-Cysteine)FDA Link
01/2021 |
1 | sotorasibIBA
01/2021 |
1 | serum P-component (CIt)IBA
01/2021 |
1 | Blood Proteins (Serum Proteins)IBA
01/2021 |
1 | RNA (Ribonucleic Acid)IBA
01/2021 |
1 | Alanine Transaminase (SGPT)IBA
01/2020 |
1 | Carrier Proteins (Binding Protein)IBA
01/2019 |
1 | sitravatinibIBA
01/2019 |
1 | Histone Deacetylase InhibitorsIBA
01/2019 |
1 | AcetyltransferasesIBA
01/2019 |
1 | CREB-Binding ProteinIBA
01/2019 |
1 | Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2019 |